NO801024L - Nye flavonderivater, fremstilling og preparater av disse - Google Patents
Nye flavonderivater, fremstilling og preparater av disseInfo
- Publication number
- NO801024L NO801024L NO801024A NO801024A NO801024L NO 801024 L NO801024 L NO 801024L NO 801024 A NO801024 A NO 801024A NO 801024 A NO801024 A NO 801024A NO 801024 L NO801024 L NO 801024L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- lower alkoxy
- dihydroxy
- alkoxy
- acid
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical class O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 title claims 2
- 238000002360 preparation method Methods 0.000 title description 2
- -1 nicotinoyloxy Chemical group 0.000 claims description 26
- 125000003545 alkoxy group Chemical group 0.000 claims description 25
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 11
- 125000004423 acyloxy group Chemical group 0.000 claims description 9
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 8
- 150000001991 dicarboxylic acids Chemical class 0.000 claims description 7
- QCXJEYYXVJIFCE-UHFFFAOYSA-N 4-acetamidobenzoic acid Chemical compound CC(=O)NC1=CC=C(C(O)=O)C=C1 QCXJEYYXVJIFCE-UHFFFAOYSA-N 0.000 claims description 6
- 125000003051 glycosyloxy group Chemical group 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- DGIHNQMHJUSGBB-UHFFFAOYSA-N (4-acetamidobenzoyl) 4-acetamidobenzoate Chemical compound C1=CC(NC(=O)C)=CC=C1C(=O)OC(=O)C1=CC=C(NC(C)=O)C=C1 DGIHNQMHJUSGBB-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims description 2
- 239000011664 nicotinic acid Chemical class 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- AMZYHFOAWQBRRS-UHFFFAOYSA-N 3-ethoxy-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxychromen-4-one Chemical compound O1C2=CC(OC)=CC(O)=C2C(=O)C(OCC)=C1C1=CC=C(O)C(OC)=C1 AMZYHFOAWQBRRS-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims 1
- 229930003944 flavone Natural products 0.000 claims 1
- 235000011949 flavones Nutrition 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 33
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 30
- 239000000243 solution Substances 0.000 description 24
- 238000002844 melting Methods 0.000 description 23
- 230000008018 melting Effects 0.000 description 23
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 230000000840 anti-viral effect Effects 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- 238000001953 recrystallisation Methods 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- KQFUXLQBMQGNRT-UHFFFAOYSA-N pachypodol Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(OC)=C1 KQFUXLQBMQGNRT-UHFFFAOYSA-N 0.000 description 6
- UOJMTSCORVQOHS-UHFFFAOYSA-N pachypodol Natural products COc1cc(ccc1O)C2=C(C)C(=O)c3c(O)cc(C)cc3O2 UOJMTSCORVQOHS-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 241000709661 Enterovirus Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 5
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 241000709687 Coxsackievirus Species 0.000 description 4
- BJBUTJQYZDYRMJ-UHFFFAOYSA-N Kaempferol 3,7-dimethyl ether Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C=C1 BJBUTJQYZDYRMJ-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000709677 Coxsackievirus B1 Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000000120 cytopathologic effect Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YGMHIBLUWGDWKP-UHFFFAOYSA-N (4-methoxybenzoyl) 4-methoxybenzoate Chemical compound C1=CC(OC)=CC=C1C(=O)OC(=O)C1=CC=C(OC)C=C1 YGMHIBLUWGDWKP-UHFFFAOYSA-N 0.000 description 2
- RKFVMFXMOKRKHI-UHFFFAOYSA-N 2-(4-aminophenyl)-5,7-dihydroxy-3-methoxychromen-4-one Chemical compound O1C2=CC(O)=CC(O)=C2C(=O)C(OC)=C1C1=CC=C(N)C=C1 RKFVMFXMOKRKHI-UHFFFAOYSA-N 0.000 description 2
- WSQWAMGRHJQANC-UHFFFAOYSA-N 3,4',7-Trimethylkaempferol Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(O)C=C(OC)C=C2O1 WSQWAMGRHJQANC-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- AUHSZRKTVWRTAA-UHFFFAOYSA-N [4-(5-ethoxycarbonyloxy-3,7-dimethoxy-4-oxochromen-2-yl)-2-methoxyphenyl] ethyl carbonate Chemical compound C1=C(OC)C(OC(=O)OCC)=CC=C1C1=C(OC)C(=O)C2=C(OC(=O)OCC)C=C(OC)C=C2O1 AUHSZRKTVWRTAA-UHFFFAOYSA-N 0.000 description 2
- JMNWVSMCCHOWRN-UHFFFAOYSA-N [4-(5-hydroxy-3,7-dimethoxy-4-oxochromen-2-yl)-2-methoxyphenyl] 2,2-dimethylpropanoate Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(OC(=O)C(C)(C)C)C(OC)=C1 JMNWVSMCCHOWRN-UHFFFAOYSA-N 0.000 description 2
- OHYCXRVUXQZCQX-UHFFFAOYSA-N [4-[3,7-dimethoxy-5-(2-methylpropanoyloxy)-4-oxochromen-2-yl]-2-methoxyphenyl] 2,2-dimethylpropanoate Chemical compound C=1C(OC)=CC(OC(=O)C(C)C)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(OC(=O)C(C)(C)C)C(OC)=C1 OHYCXRVUXQZCQX-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- LOQXTRPEVWKWKG-UHFFFAOYSA-N (2-methoxy-4-phenylmethoxybenzoyl) 2-methoxy-4-phenylmethoxybenzoate Chemical compound C=1C=C(C(=O)OC(=O)C=2C(=CC(OCC=3C=CC=CC=3)=CC=2)OC)C(OC)=CC=1OCC1=CC=CC=C1 LOQXTRPEVWKWKG-UHFFFAOYSA-N 0.000 description 1
- JIMLDJNLXLMGLX-JTQLQIEISA-N (2s)-5-amino-5-oxo-2-(phenylmethoxycarbonylamino)pentanoic acid Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 JIMLDJNLXLMGLX-JTQLQIEISA-N 0.000 description 1
- ZSKPRSCIVQDZDS-UHFFFAOYSA-N (3-methoxy-4-phenylmethoxybenzoyl) 3-methoxy-4-phenylmethoxybenzoate Chemical compound COC1=CC(C(=O)OC(=O)C=2C=C(OC)C(OCC=3C=CC=CC=3)=CC=2)=CC=C1OCC1=CC=CC=C1 ZSKPRSCIVQDZDS-UHFFFAOYSA-N 0.000 description 1
- MCWOIFCXBMZSBD-UHFFFAOYSA-N (4-methoxy-3-phenylmethoxybenzoyl) 4-methoxy-3-phenylmethoxybenzoate Chemical compound COC1=CC=C(C(=O)OC(=O)C=2C=C(OCC=3C=CC=CC=3)C(OC)=CC=2)C=C1OCC1=CC=CC=C1 MCWOIFCXBMZSBD-UHFFFAOYSA-N 0.000 description 1
- KVVRJYYXGYCCLY-UHFFFAOYSA-N (4-phenylmethoxybenzoyl) 4-phenylmethoxybenzoate Chemical compound C=1C=C(OCC=2C=CC=CC=2)C=CC=1C(=O)OC(=O)C(C=C1)=CC=C1OCC1=CC=CC=C1 KVVRJYYXGYCCLY-UHFFFAOYSA-N 0.000 description 1
- SGQLQPOIEQFQTN-ZOWNYOTGSA-N (4s)-4-amino-5-[4-(5-hydroxy-3,7-dimethoxy-4-oxochromen-2-yl)-2-methoxyphenoxy]-5-oxopentanoic acid;hydrobromide Chemical compound Br.C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(OC(=O)[C@@H](N)CCC(O)=O)C(OC)=C1 SGQLQPOIEQFQTN-ZOWNYOTGSA-N 0.000 description 1
- ICLYJLBTOGPLMC-KVVVOXFISA-N (z)-octadec-9-enoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCC\C=C/CCCCCCCC(O)=O ICLYJLBTOGPLMC-KVVVOXFISA-N 0.000 description 1
- MKLYGUJAWHZWFN-UHFFFAOYSA-N 1-(2,6-dihydroxy-4-methoxyphenyl)-2-propan-2-yloxyethanone Chemical compound COC1=CC(O)=C(C(=O)COC(C)C)C(O)=C1 MKLYGUJAWHZWFN-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- OELSSIOJNMJDSF-UHFFFAOYSA-N 2,3-dihydroxy-4-[4-(5-hydroxy-3,7-dimethoxy-4-oxochromen-2-yl)-2-methoxyphenoxy]-4-oxobutanoic acid Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(OC(=O)C(O)C(O)C(O)=O)C(OC)=C1 OELSSIOJNMJDSF-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- FLDKKYLUKGODNQ-UHFFFAOYSA-N 2-(4-aminophenyl)-5-hydroxy-3,7-dimethoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(N)C=C1 FLDKKYLUKGODNQ-UHFFFAOYSA-N 0.000 description 1
- DGMOBVGABMBZSB-UHFFFAOYSA-N 2-methylpropanoyl chloride Chemical compound CC(C)C(Cl)=O DGMOBVGABMBZSB-UHFFFAOYSA-N 0.000 description 1
- KPCRYSMUMBNTCK-UHFFFAOYSA-N 3',5-dihydroxy-3,4',7-trimethoxyflavone Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(OC)C(O)=C1 KPCRYSMUMBNTCK-UHFFFAOYSA-N 0.000 description 1
- RJCJVIFSIXKSAH-UHFFFAOYSA-N 3,4'-dimethylkaempferol Chemical compound C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(O)C=C(O)C=C2O1 RJCJVIFSIXKSAH-UHFFFAOYSA-N 0.000 description 1
- MLYYOHQNXPDGGV-UHFFFAOYSA-N 3,5-dimethoxy-2-phenylchromen-4-one Chemical compound COC=1C(=O)C=2C(OC)=CC=CC=2OC=1C1=CC=CC=C1 MLYYOHQNXPDGGV-UHFFFAOYSA-N 0.000 description 1
- UZGLOGCJCWBBIV-UHFFFAOYSA-N 3-(chloromethyl)pyridin-1-ium;chloride Chemical compound Cl.ClCC1=CC=CN=C1 UZGLOGCJCWBBIV-UHFFFAOYSA-N 0.000 description 1
- ROUBTGBVCGLQRT-UHFFFAOYSA-N 5,6-dihydroxy-3,7-dimethoxy-2-phenylchromen-4-one Chemical compound COC=1C(=O)C=2C(O)=C(O)C(OC)=CC=2OC=1C1=CC=CC=C1 ROUBTGBVCGLQRT-UHFFFAOYSA-N 0.000 description 1
- LHEJDBBHZGISGW-UHFFFAOYSA-N 5-fluoro-3-(3-oxo-1h-2-benzofuran-1-yl)-1h-pyrimidine-2,4-dione Chemical compound O=C1C(F)=CNC(=O)N1C1C2=CC=CC=C2C(=O)O1 LHEJDBBHZGISGW-UHFFFAOYSA-N 0.000 description 1
- 208000002077 Coxsackievirus Infections Diseases 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- SVWWOYQFWYYDLH-UHFFFAOYSA-N Ermanin Natural products COC1C(Oc2cc(O)cc(O)c2C1=O)c3ccc(OC)cc3 SVWWOYQFWYYDLH-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000430519 Human rhinovirus sp. Species 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010061494 Rhinovirus infection Diseases 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- CYAYKKUWALRRPA-RGDJUOJXSA-N [(2r,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-bromooxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@H]1O[C@H](Br)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O CYAYKKUWALRRPA-RGDJUOJXSA-N 0.000 description 1
- CHHHDBIYMPJYLB-UHFFFAOYSA-N [4-(3,7-dimethoxy-4-oxo-5-propanoyloxychromen-2-yl)-2-methoxyphenyl] propanoate Chemical compound C1=C(OC)C(OC(=O)CC)=CC=C1C1=C(OC)C(=O)C2=C(OC(=O)CC)C=C(OC)C=C2O1 CHHHDBIYMPJYLB-UHFFFAOYSA-N 0.000 description 1
- KKLNIZIIWNRCNN-JTQLQIEISA-N [4-(5-hydroxy-3,7-dimethoxy-4-oxochromen-2-yl)-2-methoxyphenyl] (2s)-2-aminopropanoate Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(OC(=O)[C@H](C)N)C(OC)=C1 KKLNIZIIWNRCNN-JTQLQIEISA-N 0.000 description 1
- JBWVEEJCIGBJQO-UHFFFAOYSA-N [4-(5-hydroxy-3,7-dimethoxy-4-oxochromen-2-yl)-2-methoxyphenyl] acetate Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(OC(C)=O)C(OC)=C1 JBWVEEJCIGBJQO-UHFFFAOYSA-N 0.000 description 1
- IUJKWETXANBZPF-UHFFFAOYSA-N [4-[3,7-dimethoxy-4-oxo-5-(pyridine-3-carbonyloxy)chromen-2-yl]-2-methoxyphenyl] pyridine-3-carboxylate Chemical compound O1C(C=2C=C(OC)C(OC(=O)C=3C=NC=CC=3)=CC=2)=C(OC)C(=O)C=2C1=CC(OC)=CC=2OC(=O)C1=CC=CN=C1 IUJKWETXANBZPF-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 238000001720 action spectrum Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- ZLASJWLZBYSLDG-UHFFFAOYSA-M potassium;4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C=C1 ZLASJWLZBYSLDG-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- IIXVGSLUOUGCNU-UHFFFAOYSA-M sodium;2-methoxy-4-phenylmethoxybenzoate Chemical compound [Na+].C1=C(C([O-])=O)C(OC)=CC(OCC=2C=CC=CC=2)=C1 IIXVGSLUOUGCNU-UHFFFAOYSA-M 0.000 description 1
- OGRZCYWSKAPOSR-UHFFFAOYSA-M sodium;3-methoxy-4-phenylmethoxybenzoate Chemical compound [Na+].COC1=CC(C([O-])=O)=CC=C1OCC1=CC=CC=C1 OGRZCYWSKAPOSR-UHFFFAOYSA-M 0.000 description 1
- QCTHGBUDZUJILN-UHFFFAOYSA-M sodium;4-acetamidobenzoate Chemical compound [Na+].CC(=O)NC1=CC=C(C([O-])=O)C=C1 QCTHGBUDZUJILN-UHFFFAOYSA-M 0.000 description 1
- AETSDHMVQHOYPB-UHFFFAOYSA-M sodium;4-methoxybenzoate Chemical compound [Na+].COC1=CC=C(C([O-])=O)C=C1 AETSDHMVQHOYPB-UHFFFAOYSA-M 0.000 description 1
- WOUZNSRCJPRTHA-UHFFFAOYSA-M sodium;4-phenylmethoxybenzoate Chemical compound [Na+].C1=CC(C(=O)[O-])=CC=C1OCC1=CC=CC=C1 WOUZNSRCJPRTHA-UHFFFAOYSA-M 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7912610 | 1979-04-10 | ||
| GB8006259 | 1980-02-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO801024L true NO801024L (no) | 1980-10-13 |
Family
ID=26271208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO801024A NO801024L (no) | 1979-04-10 | 1980-04-09 | Nye flavonderivater, fremstilling og preparater av disse |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4352792A (sv) |
| EP (1) | EP0019081B1 (sv) |
| JP (1) | JPH01117879A (sv) |
| AU (1) | AU538214B2 (sv) |
| CU (1) | CU35257A (sv) |
| DE (1) | DE3069488D1 (sv) |
| DK (1) | DK152980A (sv) |
| FI (1) | FI801050A7 (sv) |
| IE (1) | IE49670B1 (sv) |
| IL (1) | IL59770A (sv) |
| MC (1) | MC1316A1 (sv) |
| NO (1) | NO801024L (sv) |
| NZ (1) | NZ193316A (sv) |
| PH (1) | PH17987A (sv) |
| PT (1) | PT71078B (sv) |
| ZW (1) | ZW8180A1 (sv) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2543140B1 (fr) * | 1983-03-24 | 1985-06-21 | Cortial | Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique |
| FR2543550B1 (fr) * | 1983-04-01 | 1985-08-09 | Cortial | Nouveaux derives de la tetrahydroxy-3', 4',5,7 flavone, leur methode de preparation et leur emploi therapeutique |
| DE3505611A1 (de) * | 1984-11-26 | 1986-05-28 | Merck Patent Gmbh, 6100 Darmstadt | Halogen-hydroxy-flavone |
| FR2593066B1 (fr) * | 1986-01-17 | 1989-06-30 | Pasteur Institut | Compositions therapeutiques a base de derives de 3-alkoxyflavones et nouveaux derives de 3-alkoxyflavones. |
| USH1427H (en) * | 1988-04-06 | 1995-04-04 | Briet; Phillipe | Substituted flavonoid compounds, their salts, their manufacture and their use in combination with interleukin-2 |
| US5185366A (en) * | 1990-07-31 | 1993-02-09 | Ohio State University Research Foundation | Method for treatment and prevention of diseases caused by enveloped viruses, including herpes simplex virus types 1 and 2 diseases, using 3,4-dihydroxy-2H-benzopyran-2H-one |
| US5449794A (en) * | 1991-02-15 | 1995-09-12 | Jasmine Fockerman | Benzopyran phenol derivatives for use as antibacterial agents |
| US5591771A (en) * | 1991-12-17 | 1997-01-07 | Michel Fockerman | Use of propolis components as an adjuvant |
| US5861430A (en) * | 1991-12-17 | 1999-01-19 | Jasmine Fockerman | Benzopyran phenol derivates for use as antibacterial, antiviral or immunostimulating agents |
| EP0584365B1 (en) * | 1992-03-12 | 1997-04-16 | Sanwa Shoyaku Kabushiki Kaisha | Novel hair growth/restoration promoter |
| GB9613455D0 (en) * | 1996-06-27 | 1996-08-28 | Aston Molecules Ltd | Analogues or derivatives of quercetin |
| US6083921A (en) * | 1998-01-12 | 2000-07-04 | Xu; Kai Jian | Pharmaceutical compositions and method of using same |
| FR2778663B1 (fr) | 1998-05-15 | 2001-05-18 | Coletica | Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire |
| IT1304304B1 (it) * | 1998-10-30 | 2001-03-15 | Euro Pharma S R L | Prodotti per l'igiene personale a base di estratti di lapachocontenenti quercetina ed eventuali altri chinoni presenti nel lapacho |
| EP1223928A2 (en) | 1999-07-08 | 2002-07-24 | Patrick Thomas Prendergast | Use of flavones, coumarins and related compounds to treat infections |
| WO2001021608A2 (en) * | 1999-09-23 | 2001-03-29 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Novel flavonoids |
| JP4654187B2 (ja) * | 2003-05-15 | 2011-03-16 | 成都迪康▲ヤオ▼物研究所 | テクトリゲニンのイソフラボン誘導体、その調製、および有効成分としてこれを含む抗ウィルス剤 |
| JP2007516937A (ja) * | 2003-06-20 | 2007-06-28 | コグニス・フランス・ソシエテ・パール・アクシオン・サンプリフィエ | フラボノイドとω−置換Ｃ６〜Ｃ２２脂肪酸とのエステル |
| CN1990479A (zh) * | 2005-12-29 | 2007-07-04 | 中国科学院上海药物研究所 | 3－烷氧取代－2,5,7－三取代苯并吡喃－4－酮类化合物及其制备方法和包含该类化合物的药物组合物 |
| AU2006233256B2 (en) * | 2006-10-30 | 2012-01-19 | Armaron Bio Pty Ltd | Improved flavonols |
| EP3594209A1 (en) * | 2018-07-13 | 2020-01-15 | Centre National De La Recherche Scientifique (Cnrs) | Lipophenolic flavonoid derivatives useful to reduce carbonyl and oxidative stresses (cos) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3336198A (en) * | 1964-02-14 | 1967-08-15 | Ciba Geigy Corp | Aminomethyl derivatives of rutin and process for the manufacture thereof |
| FR1578715A (sv) * | 1967-07-26 | 1969-08-22 | ||
| FR95487E (fr) | 1967-07-26 | 1971-01-15 | Rech S Ind Sori Soc D | Nouveaux dérives flavoniques. |
| FR2088127B1 (sv) * | 1970-05-21 | 1973-04-06 | Biosedra Lab | |
| US4105781A (en) * | 1970-12-30 | 1978-08-08 | Fujisawa Pharmaceutical Co., Ltd. | Chromone compounds and preparation thereof |
| GB1461777A (en) * | 1973-06-08 | 1977-01-19 | Fisons Ltd | 2-phenyl-4-oxo-4h-1-benzopyran derivatives |
| HU166380B (sv) * | 1973-07-09 | 1975-03-28 | ||
| JPS5035393A (sv) * | 1973-08-01 | 1975-04-04 | ||
| US4150038A (en) * | 1977-05-16 | 1979-04-17 | Dynapol | Conversion of hesperidin into hesperetin |
| DE2740950A1 (de) * | 1977-09-10 | 1979-03-22 | Merck Patent Gmbh | Verfahren zur herstellung von flavonen |
| FI790863A7 (fi) * | 1978-03-15 | 1979-09-16 | Wellcome Found | Kemoterapeutiskt aemne |
-
1980
- 1980-03-31 NZ NZ193316A patent/NZ193316A/en unknown
- 1980-04-02 FI FI801050A patent/FI801050A7/sv not_active Application Discontinuation
- 1980-04-03 ZW ZW81/80A patent/ZW8180A1/xx unknown
- 1980-04-03 AU AU57157/80A patent/AU538214B2/en not_active Ceased
- 1980-04-03 MC MC801442A patent/MC1316A1/fr unknown
- 1980-04-04 IL IL59770A patent/IL59770A/xx unknown
- 1980-04-07 US US06/137,637 patent/US4352792A/en not_active Expired - Lifetime
- 1980-04-09 PT PT71078A patent/PT71078B/pt unknown
- 1980-04-09 IE IE711/80A patent/IE49670B1/en unknown
- 1980-04-09 NO NO801024A patent/NO801024L/no unknown
- 1980-04-09 DK DK152980A patent/DK152980A/da not_active IP Right Cessation
- 1980-04-09 EP EP80101894A patent/EP0019081B1/de not_active Expired
- 1980-04-09 DE DE8080101894T patent/DE3069488D1/de not_active Expired
- 1980-04-09 PH PH23875A patent/PH17987A/en unknown
- 1980-04-10 CU CU8035257A patent/CU35257A/es unknown
-
1988
- 1988-09-22 JP JP63236640A patent/JPH01117879A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU5715780A (en) | 1980-10-16 |
| IL59770A0 (en) | 1980-06-30 |
| EP0019081B1 (de) | 1984-10-24 |
| AU538214B2 (en) | 1984-08-02 |
| CU35257A (en) | 1982-03-28 |
| EP0019081A1 (de) | 1980-11-26 |
| PT71078A (en) | 1980-05-01 |
| IL59770A (en) | 1984-07-31 |
| PH17987A (en) | 1985-02-28 |
| ZW8180A1 (en) | 1980-11-05 |
| IE49670B1 (en) | 1985-11-13 |
| NZ193316A (en) | 1984-07-31 |
| DE3069488D1 (en) | 1984-11-29 |
| IE800711L (en) | 1980-10-10 |
| US4352792A (en) | 1982-10-05 |
| JPH01117879A (ja) | 1989-05-10 |
| DK152980A (da) | 1980-10-15 |
| MC1316A1 (fr) | 1981-03-10 |
| FI801050A7 (sv) | 1981-01-01 |
| PT71078B (en) | 1981-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO801024L (no) | Nye flavonderivater, fremstilling og preparater av disse | |
| Deutsch et al. | Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity | |
| US20010041674A1 (en) | C-glycosides and preparation of thereof as antidiabetic agents | |
| Linardi et al. | Lapachol derivative active against mouse lymphocytic leukemia P-388 | |
| JPH03188042A (ja) | キノン誘導体 | |
| US4605674A (en) | Substituted acetophenones and compositions containing them | |
| EP0984934B1 (en) | Novel orally active iron (iii) chelators | |
| Mateeva et al. | Synthesis of novel flavonoid derivatives as potential HIV‐Integrase inhibitors | |
| JPH01131156A (ja) | ピペリジン誘導体 | |
| US4327088A (en) | Phosphonooxy- or glycosyloxy-substituted acrylophenones, compositions and uses thereof | |
| JPH0118049B2 (sv) | ||
| CN115160399B (zh) | 一种皂皮酸类化合物及其制备方法和医用用途 | |
| US5292751A (en) | 5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-(1-propyl))piperidinyl)-4H-1-benzopyran-4-one, its preparation and its use | |
| Geissman | Chromones. IV. The Conversion of Khellol into Visnagin. Derivatives of Khellol and Visnagin | |
| RU2024542C1 (ru) | ГЛИКОПЕПТИД β-ГЛИЦИРРИЗИНОВОЙ КИСЛОТЫ С МЕТИЛОВЫМ ЭФИРОМ ГЛИЦИЛ-L-ВАЛИНА, ПРОЯВЛЯЮЩИЙ АНТИ-СПИД-АКТИВНОСТЬ | |
| US4013770A (en) | Antiviral 5-(substituted benzal) hydantoins | |
| EP1322632A1 (en) | N-disubstituted carbamoyloxy flavones | |
| CN108078993B (zh) | 6-硝基喹唑啉类化合物在制备治疗肺癌药物中的应用 | |
| US4371546A (en) | Benzophenone derivatives | |
| KR20250059517A (ko) | 케토아미드 유도체의 무정형 및 그 제조 방법 | |
| US4725620A (en) | 2H-pyran-2,6-(3H)-dione derivatives with anti-allergic activity | |
| JPH02121982A (ja) | エライオフイリン誘導体 | |
| JPS61257981A (ja) | ジベンズ〔ｂ，ｅ〕オキセピン誘導体および抗アレルギ−剤 | |
| CA1074803A (en) | 1-thiazolinyl-5(6)-substituted-ben-zimidazoles | |
| HRP20020352A2 (en) | Aromatic di-keto derivatives, processes for their production and their use as pharmaceutical |